Congress has passed the new Procurement Law and we are now able to verify the impact we have had: the majority of Civio's anti-opacity recommendations have been included - either directly or indirectly - in the regulation. Let's look more closely at the mark we’ve made.
All these countries publish a declared portion – how much each doctor received from each firm – and an anonymous portion, published as an aggregate figure without names. It is partial transparency.
Countries with very different incomes pay similar prices for accessing the new medicines, while states continue to play along the secrecy imposed by pharmaceutical companies.
We are an independent non-profit organization that monitors public authorities through data- and facts-based research, throwing light on the blind spots in the system. We lobby and collaborate with public bodies to bring effective change.
We thoroughly investigate power, public procurement, pardons, conflicts of interest and many other important issues.
We lobby to bring an end to opacity in public affairs and to achieve free access to key information generated by our institutions.
We cooperate with public administrations to provide innovative and effective solutions to the citizens' demand for transparency.
More recent stories